Gonadal Steroid Manipulation and Personality Characteristics: Association With Mood Fluctuations and in Vitro Fertilization (IVF) Outcomes
IVF
1 other identifier
observational
100
0 countries
N/A
Brief Summary
The current study's primary aim is to investigate the association between neuroendocrine fluctuations and mood disorders by monitoring mood states over distinct hormonal phases during in-vitro-fertilization (IVF) treatment. The secondary goal of this study is to explore psychological profiles and coping mechanisms of women undergoing IVF, and to identify the ones that are associated with successful psychological adaptation to the process and a successful biological outcome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2006
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2007
CompletedFirst Submitted
Initial submission to the registry
November 25, 2009
CompletedFirst Posted
Study publicly available on registry
December 15, 2009
CompletedDecember 15, 2009
December 1, 2009
1.9 years
November 25, 2009
December 13, 2009
Conditions
Keywords
Study Arms (1)
GNRH
Observational (IVF is not done as part of the study)
Interventions
Eligibility Criteria
Women admitted for their first or second IVF cycle, under the age of 42. Please see the detailed inclusion and exclusion criteria.
You may qualify if:
- Admitted for their first or second IVF cycle;
- Demonstrated sufficient communication skills and level of understanding in the Hebrew language;
- signed an informed consent;
- Were under the age of 42;
- Were not suffering from endometriosis or male factor in patients who underwent testicular sperm extraction (TESE);
- Were not under psychotherapeutic or psychopharmacological treatment. The accepted indications for the IVF included a female factor, male factor or unexplained infertility.
You may not qualify if:
- \. All others.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (2)
Zaig I, Azem F, Schreiber S, Amit A, Litvin YG, Bloch M. Psychological response and cortisol reactivity to in vitro fertilization treatment in women with a lifetime anxiety or unipolar mood disorder diagnosis. J Clin Psychiatry. 2013 Apr;74(4):386-92. doi: 10.4088/JCP.12m07805.
PMID: 23656846DERIVEDBloch M, Azem F, Aharonov I, Ben Avi I, Yagil Y, Schreiber S, Amit A, Weizman A. GnRH-agonist induced depressive and anxiety symptoms during in vitro fertilization-embryo transfer cycles. Fertil Steril. 2011 Jan;95(1):307-9. doi: 10.1016/j.fertnstert.2010.07.1073.
PMID: 20801439DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
Study Record Dates
First Submitted
November 25, 2009
First Posted
December 15, 2009
Study Start
January 1, 2006
Primary Completion
December 1, 2007
Study Completion
December 1, 2007
Last Updated
December 15, 2009
Record last verified: 2009-12